PT4294257T - Método para diagnóstico e tratamento da lipodistrofia parcial - Google Patents

Método para diagnóstico e tratamento da lipodistrofia parcial

Info

Publication number
PT4294257T
PT4294257T PT227086980T PT22708698T PT4294257T PT 4294257 T PT4294257 T PT 4294257T PT 227086980 T PT227086980 T PT 227086980T PT 22708698 T PT22708698 T PT 22708698T PT 4294257 T PT4294257 T PT 4294257T
Authority
PT
Portugal
Prior art keywords
diagnosing
partial lipodystrophy
treating partial
treating
lipodystrophy
Prior art date
Application number
PT227086980T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of PT4294257T publication Critical patent/PT4294257T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4869Determining body composition
    • A61B5/4872Body fat
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • A61B5/7275Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48Diagnostic techniques
    • A61B6/482Diagnostic techniques involving multiple energy imaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/52Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5211Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
    • A61B6/5217Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Data Mining & Analysis (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biotechnology (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Artificial Intelligence (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dentistry (AREA)
  • Software Systems (AREA)
  • Bioethics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Evolutionary Computation (AREA)
PT227086980T 2021-02-22 2022-02-22 Método para diagnóstico e tratamento da lipodistrofia parcial PT4294257T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163152100P 2021-02-22 2021-02-22

Publications (1)

Publication Number Publication Date
PT4294257T true PT4294257T (pt) 2025-11-28

Family

ID=80683255

Family Applications (1)

Application Number Title Priority Date Filing Date
PT227086980T PT4294257T (pt) 2021-02-22 2022-02-22 Método para diagnóstico e tratamento da lipodistrofia parcial

Country Status (14)

Country Link
US (1) US20240153638A1 (https=)
EP (1) EP4294257B1 (https=)
JP (1) JP2024512255A (https=)
DK (1) DK4294257T3 (https=)
ES (1) ES3055018T3 (https=)
FI (1) FI4294257T3 (https=)
HR (1) HRP20251599T1 (https=)
LT (1) LT4294257T (https=)
PL (1) PL4294257T3 (https=)
PT (1) PT4294257T (https=)
RS (1) RS67523B1 (https=)
SI (1) SI4294257T1 (https=)
SM (1) SMT202500444T1 (https=)
WO (1) WO2022178382A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso
MX2021008661A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202417497A (zh) 2015-10-12 2024-05-01 美商再生元醫藥公司 活化瘦素受體的抗原結合蛋白
PT3773713T (pt) * 2018-04-06 2025-07-29 Regeneron Pharma Anticorpo agonista do recetor de leptina para usar no aumento da massa óssea num sujeito que sofre de disfunção metabólica ou de hipoleptinemia

Also Published As

Publication number Publication date
WO2022178382A1 (en) 2022-08-25
SI4294257T1 (sl) 2026-01-30
JP2024512255A (ja) 2024-03-19
US20240153638A1 (en) 2024-05-09
HRP20251599T1 (hr) 2026-01-30
DK4294257T3 (da) 2025-12-08
SMT202500444T1 (it) 2026-01-12
RS67523B1 (sr) 2026-01-30
PL4294257T3 (pl) 2026-02-09
EP4294257A1 (en) 2023-12-27
FI4294257T3 (fi) 2025-12-19
LT4294257T (lt) 2025-12-29
EP4294257B1 (en) 2025-11-05
ES3055018T3 (en) 2026-02-09

Similar Documents

Publication Publication Date Title
SMT202500444T1 (it) Metodo per la diagnosi e il trattamento della lipodistrofia parziale
GB2593487B (en) Apparatus and method
GB2592661B (en) An apparatus and method for performing branch prediction
KR102625873B9 (ko) 근감소증 예방, 치료 또는 개선용 조성물 및 근감소증을 진단하는 방법
GB202009758D0 (en) Apparatus and method
ES3063538T3 (en) Kit and method for treating skin
KR102315936B9 (ko) 하이브리드 수처리 장치 및 방법
IL320641A (en) Method for treating and/or preventing cellulite
GB202006832D0 (en) Apparatus and method
GB202003075D0 (en) Apparatus and method
GB202001782D0 (en) Apparatus and method
GB202203546D0 (en) Component treatment method and apparatus
GB202114945D0 (en) Method and apparatus
GB202009424D0 (en) Apparatus and method
GB202007936D0 (en) Apparatus and method
GB202007689D0 (en) Method and apparatus
GB202007346D0 (en) Method and apparatus
GB202005931D0 (en) Apparatus and method
GB2610672B (en) Line diagnosis method and apparatus
GB2599917B (en) Apparatus and method for covering opening
GB2599638B (en) Wire treatment method and apparatus
PL4035785T3 (pl) Sposób i urządzenie do obróbki elementów
GB202010833D0 (en) Method and apparatus
GB202010253D0 (en) Method and apparatus
GB202010011D0 (en) Apparatus and method